Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.84626 | 64 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.712 | 62 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.71679 | 62 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.63623 | 61 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.70792 | 63 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.82693 | 63 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.81867 | 63 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.75287 | 63 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.71935 | 62 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.67967 | 62 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.73376 | 63 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.65032 | 62 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.81002 | 63 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.73625 | 63 |